Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

19 December 2001

Antihypertensive Treatment in Renal Transplant Patients- is There a Role for ACE Inhibitors?

Martin Hausberg, Markus Kosch, Helge Hohage, Barbara Suwelack, Michael Barenbrock, Klaus Kisters, Karl Heinz Rahn

Ann Transplant 2001; 6(4): 31-37 :: ID: 497810

Abstract

During the past two decades great progress was achieved with regards to short-term kidney graft survival. However. long-term graft survival did not improve similarly. Many factors contribute to chronic graft nephropathy eventually resulting in late graft loss. among these arterial hypertension is of major importance. In patients with chronic renal disease of diabetic and non-diabetic origin. angiotensin converting enzyme inhibitors avebeenconvincingly shown to slow the progression of renal failure. The achieved nephroprotection correlates with the reduction of proteinuria by ACE inhibitor treatment. Also in renal transplant patients. ACE inhibitors have been shown unequivocally to reduce urinary protein excretion. The prevention of hyperfiltration. particular in the context of a reduced number of functional nephrons in patients with chronic graft nephropathy. could be important to prolong graft survival after renal transplantation. Moreover. ACE inhibitors may exert beneficial effects on immunologic processes contributing to chronic graft nephropathy. Many studies published in the last decade show convincingly that ACE inhibitors are safe and effective for the treatment of hypertension in renal allograftrecipients. However, no data exist so farshowingthat ACE inhibitors are superior to other antihypertensive drugs in renal transplant patients and that they prolong graft survival. Studies investigating this issue are warranted. Apart from effects on the graft. ACE inhibitorsmay improve alterations of the cardiovascular system generally observed in renal transplant patients. such as structural alterations of large arteries, left ventricular hypertrophy. Disturbed mechanical vessel wall properties and endothelial dysfunction. Therefore. angiotensin converting enzyme inhibitors could reduce cardiovascular morbidity and mortality in kidney transplant patients.

Keywords: Kidney Transplantation, chronic rejection, graft nephropathy, Proteinuria, ACE inhibitor

0 Comments

In Press

04 Aug 2022 : Original article  

Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...

Ann Transplant In Press; DOI: 10.12659/AOT.936888  

22 Jul 2022 : Original article  

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...

Ann Transplant In Press; DOI: 10.12659/AOT.936937  

22 Jul 2022 : Original article  

Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...

Ann Transplant In Press; DOI: 10.12659/AOT.936732  

22 Jul 2022 : Original article  

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.936751  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358